Public Health Lessons Learned From the Coronavirus Pandemic
The United States’ struggle to respond to the virus has [...]
Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease
Donanemab is not a cure and comes with significant side [...]
F.D.A. Approves New Nasal Spray for Migraines
Pfizer’s treatment applies an approach that is different from some [...]
Start-Up Paradigm Raises $200 Million to Speed Up Drug Trials
New York-based Paradigm has raised a significant amount to simplify [...]
The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?
Janssen Pharmaceuticals ended a global trial after independent experts determined [...]
FDA Approves, Leqembi, New Treatment for Early Alzheimer’s
The drug, Leqembi, may modestly slow cognitive decline in early [...]
How Anthony Fauci Quietly Shocked AIDS Activists
An ACT UP veteran remembers the doctor’s AIDS legacy.
Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen
The report said the F.D.A.’s approval process for Aduhelm was [...]
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?
Shortages and drug-resistant germs have renewed attention on a $6 [...]
Alzheimer’s APOE4 Genetic Risk Targeted in Promising Trial
Preliminary results offer hope that gene therapy can protect people [...]